HPV vaccine implementation and monitoring in Latin America
نویسندگان
چکیده
منابع مشابه
Implementation of smoke free workplaces: challenges in Latin America.
Latin America is at the forefront of global progress in smoke free workplaces. Comprehensive smoke free laws have been implemented in four countries, and in many cities, states and provinces. More than 130 million people in Latin America are now protected from secondhand tobacco smoke. Nevertheless, a survey of tobacco control advocates and governments in Latin America found several challenges ...
متن کاملBurden of Human Papillomavirus (HPV) Infection and HPV- Related Disease in Latin America and the Caribbean, and Health and Economic Outcomes of HPV Vaccination in Selected Countries in Latin America
متن کامل
Race in Latin America
category to understand human biological diversity. Humans vary to some extent in their DNA and their outward physical appearance or phenotype, but this diversity cannot be organized into “racial groups” or “races,” even if some genetic and phenotypical variation seems to correlate very broadly with continental geography. Humans are too similar genetically and intracontinental genetic variation ...
متن کاملAcceptability of HPV vaccine implementation among parents in India.
Due to high cervical cancer rates and limited research on human papillomavirus (HPV) vaccine acceptability in India, the research team examined parental attitudes toward HPV vaccines. Thirty-six interviews with parents were conducted to assess sexually transmitted infection (STI)-related knowledge and HPV-specific vaccine awareness and acceptability. Despite limited knowledge, parents had posit...
متن کاملHPV vaccine implementation in STD clinics--STD Surveillance Network.
We surveyed selected public sexually transmitted disease clinics in the United States regarding human papillomavirus vaccine availability, target populations, funding sources, and barriers. Although nearly all had experience offering other vaccines, only 7 of 42 clinics (17%) offered human papillomavirus vaccine. Vaccine cost, staff time, and follow-up issues were commonly reported barriers.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Salud Pública de México
سال: 2018
ISSN: 1606-7916,0036-3634
DOI: 10.21149/9090